MO3-9-3Primary results from Japanese phase I study of pembrolizumab plus chemotherapy as front-line therapy for advanced NSCLCTakayasu Kurata,Kazuhiko Nakagawa,Miyako Satouchi,Takashi Seto, Takeshi Sawada,Shi Rong Han,Kazuo Noguchi,Takashi Shimamoto,Naoyuki NogamiANNALS OF ONCOLOGY(2019)引用 4|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要